Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancer

18 Nov 2020

Abstract excerpt

were identified in the training set. Risk scores were calculated to divide patients into high-risk and low-risk groups, and the high-risk patients tended to have a poor overall survival (OS). Multivariate Cox regression analysis confirmed that the IRlncRNA signature could be an independent prognostic factor. The results were subsequently confirmed in the validating set. Additionally, this 8-IRlncRNA classifier...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bladder and Urothelial Cancer Treatments
Share to Cancer-related molecular mechanisms research
Share to Ferroptosis and cancer prognosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33221763
DOI: 10.18632/aging.104115

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identification of immune-related LncRNA for predicting prognosis and immunotherapeutic response in bladder cancerPMID 33221763Read ↗

An Immune-Related lncRNA Model for Predicting Prognosis, Immune Landscape and Chemotherapeutic Response in Bladder CancerSemantic proximity Read ↗

Correlation between the immune microenvironment and bladder cancer based on a prognostic miRNA risk modelSemantic proximity Read ↗

Identification and validation of a prognostic immune-related lncRNA signature in bladder cancerSemantic proximity Read ↗

Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA)Semantic proximity Read ↗

Development and verification of immune-related long non-coding RNA prognostic signature in bladder cancerSemantic proximity Read ↗

Construction of an immune‐related LncRNA signature with prognostic significance for bladder cancerSemantic proximity Read ↗

Risk stratification based on immune signature and prediction of immune checkpoint inhibitor’s efficacy for bladder urothelial carcinomaSemantic proximity Read ↗

New exploration of bladder cancer-related immune gene biomarkers in predicting the prognosis of urinary system tumorsSemantic proximity Read ↗

Long non-coding RNAs to predict postoperative recurrence in muscle-invasive bladder cancer and to develop a new molecular classification systemSemantic proximity Read ↗

Integrated Analysis Identifies and Validates a Novel Signature Based on Immune Related Gene Predicting Survival in Bladder Urothelial CarcinomaSemantic proximity Read ↗

A TP53-Associated Immune Prognostic Signature for the Prediction of Overall Survival and Therapeutic Responses in Muscle-Invasive Bladder Cancer.Semantic proximity Read ↗

The Immunogenomic Landscape of and Immune Cell Infiltration in Bladder CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.